Acute-phase serum was collected from 124 cases of suspected typhoid fever within 7 days at the Typhoid Fever Outpatient Department during the summer and autumn from July to September 2011, at Jiashi County Hospital, Xinjiang, China. Aliquots of serum were stored at -70°C until use. The collected sera were examined for Salmonella infection and WNV infection simultaneously. 7 Salmonella infection was detected by the Widal reaction (WR). Briefly, the agglutination test was performed against the H (flagellum) and O (cell) antigens of Salmonella typhi and 'H' antigens of Salmonella paratyphi A and Salmonella paratyphi B, as described previously. 11 An acute serum sample was deemed positive when the antibody agglutination test reached O ≥ 1:80, H ≥ 1:160. WNV-and Japanese encephalitis virus (JEV)-specific IgM antibodies were detected by IgM-ELISAs (WNV IgM Capture DxSelect (Focus Diagnostics, Inc., Cypress, CA, USA) and JEV IgM Capture ELISA Kit (Panbio, Sinnamon Park, Queensland, Australia). 7 For anti-WNV IgM antibody-positive patients, sera were collected during both the acute and recovery phases, in which neutralizing antibodies against WNV and JEV were detected by the 90% plaque-reduction neutralization test (PRNT 90 ), respectively. Patients with a ≥ 4-fold difference in the WNV-neutralizing antibody titers of the convalescent serum/acute period serum samples were identified as positive for WNV infection. 12 The results of the WR indicated that 81% (101/124) of the acutephase serum samples were positive (that is, patients with typhoid fever), with WR serum geometric mean titers (95% confidence interval) of O 125 (110-142) and H 170.2 (160-186). At the same time, 34 samples were positive for anti-WNV IgM antibodies among 124 serum samples, suggesting the presence of WNV infection in patients with typhoid fever. To understand the levels of neutralizing antibodies against WNV in the acute and convalescent sera of WNV IgM-seropositive patients, we retrospectively investigated the WNV IgM-seropositive patients and collected the corresponding convalescent serum samples. In total, 21 convalescent serum samples were collected. In this study, paired acute-phase/convalescent serum samples from 21 patients were tested for WNV-neutralizing antibodies West Nile virus and febrile tyhoid co-infection L Cao et al using the PRNT 90 . The results indicate that the WNV-neutralizing antibody titer during the acute phase of WNV infection was between 1:10 and 1:20, whereas that in the convalescent sera ranged from 1:40 to 1:320. From 21 paired serum samples, there were ≥ 4-fold differences in the WNV-neutralizing antibody titer between acute and convalescent serum samples from 11 patients. Those 11 patients who were positive for anti-WNV IgM antibodies and had a ≥ 4-fold difference in WNV-neutralizing antibody titer between the convalescent/acute serum samples were identified as being positive for WNV infection (Table 1 ). To eliminate cross-neutralization reactions between JEV and WNV, the same samples were examined for JEVneutralizing antibodies at the same time. As we know, the existence of cross-reactions to one virus is usually affected by the antibody level against another virus. The results indicate that the JEV-neutralizing antibody results were negative (PRNT 90 o1:10), which were hypothesized due to low antibody levels against WNV, although some of the acute-phase serum samples were weakly positive for JEV-specific IgM antibodies. The detection of WNV nucleic acid by PCR and cell culture was performed using acute-phase serum samples from the 11 WNV-infected patients, all of which yielded negative results. The 11 WNV-infected patients were between the ages of eight and 88 years old. Among them, seven patients were ≥ 60 years old, three were 26-47 years old and one patient was eight years old. Elderly individuals were more susceptible, consistent with the observed age distribution of the WNV infection. 4, 13 Overall, five of the 11 WNV patients were found to be seropositive by WR (clinical manifestations of fever, headache, sore throat, limb weakness and hepatosplenomegaly). Laboratory testing indicated that these five patients were co-infected with Salmonella typhi and WNV, whereas the remaining six patients were negative for Salmonella typhi and had only the WNV infection (Table 1) . Jiashi County (in the Kashi Region of western China) is an economically underdeveloped area. The natural environment is mainly desolate beach and desert with perennial drought; ponds have been built to collect rainwater and snowmelt for the irrigation of farmland and livelihood is suitable for mosquito-breeding areas and habitats for WNV-competent mosquitoes (for example, Culex pipiens). Typhoid is a common infectious disease in the area. 14 To facilitate the timely treatment of typhoid patients, the Jiashi County Public Health Administrative Department set up a 'Typhoid Fever Outpatient Service' at the county hospital to provide specialized treatment for patients with typhoid fever. Patients with confirmed or suspected typhoid fever in the area during the summer were asked to first visit the Typhoid Fever Outpatient Service. The hospital conducts epidemiological investigations, provides medical examinations for patients, and collects acute-phase serum samples from suspected cases for laboratory testing. To prevent the spread and decrease the prevalence of typhoid fever, serum-positive patients are admitted to the hospital for treatment. Patients with a fever but a negative Salmonella typhi test have yet to be investigated. Patients with mild symptoms are suggested to undergo home observation, whereas severe cases are admitted to the hospital for further observation and treatment. The Typhoid Fever Outpatient Service of Jiashi County Hospital made it possible to identify patients with subclinical WNV infections in the present study.
In this study, 124 acute-phase serum samples were collected from patients with suspected typhoid fever at the Typhoid Fever Outpatient Service of Jiashi County Hospital. The laboratory test results indicated that 27% (34/124) were positive for anti-WNV IgM antibodies, of which 52% (11/21) showed a ≥ 4-fold difference in the WNVneutralizing antibody titers of convalescent/acute serum samples, suggesting a higher incidence of WNV infection in patients with fever in Jiashi, Xinjiang, China.
Among the 11 patients with a WNV infection, 5 were positive for typhoid fever, indicating that they were co-infected with Salmonella typhi and WNV (Table 1) . The clinical manifestations of Salmonella typhi and WNV co-infected patients were fever accompanied by a loss of appetite, nausea, vomiting, abdominal distension, abdominal pain and other digestive tract symptoms, whereas six patients with only a WNV infection exhibited either fever or fever with generalized symptoms. On the basis of early clinical manifestations of both groups, a WNV infection is accompanied by relatively simple clinical symptoms of fever and discomfort, whereas patients co-infected with Salmonella typhi and WNV show more complex symptoms, usually with gastrointestinal discomfort. This follow-up survey indicates that regardless of the patients' infection status (Salmonella typhi, WNV or both), the patients were all alive two to three months after infection with no aggravation of their illness and no occurrence of viral encephalitis, suggesting that these patients, and especially those with WNV infection, showed only a transient fever and a mild clinical presentation.
This study revealed that WNV infection occurred sporadically in Jiashi County, with few cases clustered in the same village, suggesting a broad distribution for WNV in the area. Although the clinical symptoms of WNV infection were relatively mild and easily ignored, changes in the local climate (such as increased temperature and rainfall) would increase the density of local mosquitos (the vector), resulting in a greater prevalence and spread of WNV. Therefore, the disease spread and risk of epidemics would be increased. The detection and monitoring of WNV infection, especially in cases of unexplained fever, are important to accurately assess the burden of WNV infection and to prevent epidemics.
